- Home
- BNTC vs ANGO Comparison
BNTC vs ANGO Comparison
Compare BNTC & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTC
- ANGO
- Stock Information
- Founded
- BNTC 1995
- ANGO 1988
- Country
- BNTC United States
- ANGO United States
- Employees
- BNTC N/A
- ANGO N/A
- Industry
- BNTC Biotechnology: Pharmaceutical Preparations
- ANGO Medical/Dental Instruments
- Sector
- BNTC Health Care
- ANGO Health Care
- Exchange
- BNTC Nasdaq
- ANGO Nasdaq
- Market Cap
- BNTC 365.1M
- ANGO 400.8M
- IPO Year
- BNTC N/A
- ANGO 2004
- Fundamental
- Price
- BNTC $13.78
- ANGO $10.81
- Analyst Decision
- BNTC Strong Buy
- ANGO Strong Buy
- Analyst Count
- BNTC 5
- ANGO 3
- Target Price
- BNTC $24.80
- ANGO $19.00
- AVG Volume (30 Days)
- BNTC 36.4K
- ANGO 370.2K
- Earning Date
- BNTC 11-13-2025
- ANGO 10-02-2025
- Dividend Yield
- BNTC N/A
- ANGO N/A
- EPS Growth
- BNTC N/A
- ANGO N/A
- EPS
- BNTC N/A
- ANGO N/A
- Revenue
- BNTC N/A
- ANGO $292,498,000.00
- Revenue This Year
- BNTC N/A
- ANGO $7.13
- Revenue Next Year
- BNTC N/A
- ANGO $6.28
- P/E Ratio
- BNTC N/A
- ANGO N/A
- Revenue Growth
- BNTC N/A
- ANGO N/A
- 52 Week Low
- BNTC $8.20
- ANGO $5.83
- 52 Week High
- BNTC $17.15
- ANGO $13.50
- Technical
- Relative Strength Index (RSI)
- BNTC 57.09
- ANGO 66.65
- Support Level
- BNTC $13.49
- ANGO $10.34
- Resistance Level
- BNTC $14.05
- ANGO $11.04
- Average True Range (ATR)
- BNTC 0.56
- ANGO 0.33
- MACD
- BNTC -0.01
- ANGO -0.01
- Stochastic Oscillator
- BNTC 64.92
- ANGO 74.59
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.